Back to Search
BENJAMIN SOLOMON, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1518209485IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
9804852-1205(UT)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
A novel SIX3 mutation segregates with holoprosencephaly in a large family.
PMID 19353631·Am J Med Genet A·2009
8-other
Dysmorphic findings in two cases of abeta/hypobetalipoproteinemia.
PMID 19282754·Clin Dysmorphol·2009
5-case
The clinical content of preconception care: genetics and genomics.
PMID 19081428·Am J Obstet Gynecol·2008
8-other
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
PMID 16170034·Mol Cancer Ther·2005
7-preclinical
EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor.
PMID 12573759·Int J Radiat Oncol Biol Phys·2003
7-preclinical
Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer.
PMID 12928126·Lung Cancer·2003
3-trial
Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin.
PMID 11720831·Eur J Cancer·2001
3-trial
Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.
PMID 19415691·Am J Med Genet B Neuropsychiatr Genet·2010
8-other
Class IA phosphatidylinositol 3-kinase signaling in non-small cell lung cancer.
PMID 19550242·J Thorac Oncol·2009
6-review
Neighborhood violence and its association with mothers' health: assessing the relative importance of perceived safety and exposure to violence.
PMID 19343500·J Urban Health·2009
8-other
The AP-1 transcription factor Batf controls T(H)17 differentiation.
PMID 19578362·Nature·2009
7-preclinical
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.
PMID 19363437·Am J Clin Oncol·2009
3-trial
Targeting children's behavior problems in preschool classrooms: a cluster-randomized controlled trial.
PMID 19309189·J Consult Clin Psychol·2009
2-rct
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
PMID 19117692·Int J Radiat Oncol Biol Phys·2009
8-other
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.
PMID 19346217·J Med Genet·2009
8-other
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
PMID 19242371·J Immunother·2009
8-other
The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.
PMID 19603532·Hum Mutat·2009
8-other
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
PMID 19667264·J Clin Oncol·2009
8-other
Modulation effect of filamentous phage on alpha-synuclein aggregation.
PMID 19379715·Biochem Biophys Res Commun·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1950 CIRCLE OF HOPE DR
SALT LAKE CITY, UT 84112 - Phone
- (801) 581-2121
Quick Facts
- NPI
- 1518209485
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile